Search by Drug Name or NDC

    NDC 68180-0518-01 Lisinopril and Hydrochlorothiazide 12.5; 10 mg/1; mg/1 Details

    Lisinopril and Hydrochlorothiazide 12.5; 10 mg/1; mg/1

    Lisinopril and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is HYDROCHLOROTHIAZIDE; LISINOPRIL.

    Product Information

    NDC 68180-0518
    Product ID 68180-518_1474b42e-df82-41d5-9cbd-ebe3c45dcc9d
    Associated GPIs 36991802550305
    GCN Sequence Number 021277
    GCN Sequence Number Description lisinopril/hydrochlorothiazide TABLET 10-12.5 MG ORAL
    HIC3 A4J
    HIC3 Description ACE INHIBITOR-THIAZIDE OR THIAZIDE-LIKE DIURETIC
    GCN 88002
    HICL Sequence Number 000131
    HICL Sequence Number Description LISINOPRIL/HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name Lisinopril and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lisinopril and Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 12.5; 10
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; LISINOPRIL
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077912
    Listing Certified Through 2024-12-31

    Package

    NDC 68180-0518-01 (68180051801)

    NDC Package Code 68180-518-01
    Billing NDC 68180051801
    Package 100 TABLET in 1 BOTTLE (68180-518-01)
    Marketing Start Date 2006-10-04
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.03236
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis